Evaluation of Neuroprotective effect of medicinal plants in Drosophila melanogaster model by Chaudhary, Prakash & Dhande, Swati
*Corresponding Author:Swati Dhande, HOD & Assistant Professor, Department of Pharmacology,  Bharati Vidyapeeth’s College 
of Pharmacy,  Sector-8, C.B.D. Belapur, Navi Mumbai, India                                                                                                                   9 
 
 
Indian J.Pharm.Biol.Res. 2018; 6(3):9-12
 
ResearchArticle 
Evaluation of Neuroprotective effect of medicinal plants in Drosophila melanogaster model 
 
Prakash Chaudhary, Swati Dhande
* 
 
HOD & Assistant Professor, Department of Pharmacology,  Bharati Vidyapeeth’s College of Pharmacy,  Sector-8, C.B.D. Belapur,  
Navi Mumbai, India 
 
ARTICLE INFO: 
Received: 25 June 2018 
Received in revised form: 
10 August 2018 
Accepted: 20 August 2018 
Available online: 30September 2018 
Keywords: 
Bombaxceiba,  
Drosophila melanogaster, 
Negative,  
Geotaxis assay,  
Rotenone 
 
 
Abstract 
In this study, we investigated the neuroprotective effects of ethanolic extract of Bombax ceiba 
(EEBC) and ethanolic extract of Gymnemasylvestre (EEGS) against the toxicity induced by 
rotenone (ROT) in Drosophila melanogaster. Materials and Methods:Adult wild-type flies 
were concomitantly exposed to ROT (500 μM), EEBC (0.05% w/v and 0.1% w/v) and EEGS 
(0.05% w/v and 0.1% w/v) in the culture medium for 7 days. Results: ROT treated flies 
produced marked decreased in locomotor performance (i.e., climbing capability) in the 
negative geotaxis assay when compared to control group. EEBC and EEGS flies after 
treatment offered protection (24-42%) against the ROT-induced locomotor impairment in the 
negative geotaxis assay suggesting attenuation of ROT-induced locomotor deficits. 
Conclusion: The results of this study suggest that EEBC and EEGS were effective in reducing 
the toxicity induced by ROT in D. melanogaster as well as it confirms the significance of this 
model to explore possible therapeutic approaches in Parkinson’s disease (PD). 
Introduction PD is a second most common neurodegenerative disease after Alzheimer’s disease. It is characterized by loss of dopaminergic neurons in the substantianigra in the mid brain resulting in depletion of dopamine, formation of filamentousintraneuronal inclusions known as Lewy bodies on the surviving dopaminergic PD is a 
PD is a second most common neurodegenerative disease after 
Alzheimer’s disease. It is characterized by loss of 
dopaminergic neurons in the substantianigra in the mid brain 
resulting in depletion of dopamine, formation of filamentous 
intraneuronal inclusions known as Lewy bodies on the 
surviving dopaminergic neurons and an extrapyramidal 
movement disorder
[1,2].
 However, free radical overproduction 
and abnormalities in mitochondria function have emerged as 
critical mediators of the dopaminergic neuronal damage
[3].
PD 
is clinically characterized by locomotor symptoms such as 
muscle rigidity, bradykinesia, postural instability and tremor 
[4]
.  
ROT a commonly used natural pesticide is a classic high 
affinity specific inhibitor of mitochondrial complex I which is 
capable of causing mitochondrial perturbations, dose-
dependent ATP depletion, oxidative damage, and early 
mortality that mimics PD. Exposure of adult flies to sub lethal 
doses of ROT in the diet over 7 days causes a 
concentrationdependentlocomotor deficits, specific 
dopaminergic neuronal loss and reduction in the dopamine 
levels in adult flies 
[5]
. 
Bombax ceiba belongs to the family Bombaceae,is one of the 
important medicinal plant.It contains various 
phytocon tituents such as vitexi , is vitexin, chlorogenic acid, 
rutin, hentriacontanol, sitosterol, isomangiferin, protoatechuic 
acid and kaempferol etc. A paste of leaves and flowers is used 
as external application for skin trouble. Seeds are applied on 
the skin in small pox and chicken pox. Leaves are used as 
laxative and hematinic. Bark is used for wound healing.It has 
various pharmacological activities like Anti-inflammatory, 
Anti-diabetic, Anti-obesity, Cytotoxicity, Aphrodisiac, 
Hypotensive, Antioxidant, Antiangiogenic, Antimicrobial, and 
Antipyretic
[6]
. 
Gymnema sylvestre belongs to the family Asclepiadaceae, 
popularly known as “gurmar” is a reputed herb in the 
Ayurvedic system of medicine used for treatment in 
conditions ranging from diabetes,malaria,to snakebites 
[7]
.The 
leaves contain major constituents like gymnemic acids and 
gymnema saponins are members of oleanane type of saponins 
while gymnemasides are dammarane saponins
[8,9]
. Other 
constituents present in it are anthraquinones, hentriacontane, 
flavones, phytin, pentatriacontane, formic acid, butyric acid, 
tartaric acid, lupeol, resins,-amyrin related glycosides, calcium 
oxalate and stigmasterol
[10]
.It is used as naturopathic treatment 
for diabetes
[11,12]
. It has also demonstrated promising effects in 
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the treatment of obesity, arthritis, hyperlipidemia, and 
hypercholesterolemia 
[13-15]
. Furthermore, the bioactive 
phytocompounds have antimicrobial, antiinflammatory, and 
anticancer properties. The leaves are used for the treatment of 
obesity [16], dental caries [17], antibiotic, in stomach ache, 
blood purifier, and in rheumatism 
[18]
. 
In the present study,the possible neuroprotective properties of 
EEBC and EEGS against ROT-induced oxidative stress and 
neurotoxicity were explored. Flies chronically exposed to 
ROT (500µM) developed selective loss of dopaminergic 
neurons in the brain and severe locomotor dysfunctions 
[19]
. 
Dietary exposure of adult flies to EEBC (0.05% w/v and 0.1% 
w/v) & EEGS (0.05% w/v and 0.1% w/v) along with ROT 
(500µM) for 7 days, thereafter its ability to modulate 
locomotor behaviour was determined by negative geotaxis 
assay. 
Chemicals: Rotenone (Sigma Aldrich) 
Gymnemasylvestre (Family:Asclepiadaceae) leaves powder 
was procured from Konark Herbal and Health Care, Daman, 
India. 
Bombaxceiba (Family:Bombaceae)bark powder wasprocured 
from the Rajesh chemicals Mumbai. 
D.melanogaster wild-type, Canton special strain was obtained 
from the Indian Institute of Science and Education Research, 
Pune, India.  
The flies were grown in length 12 cm; diameter 2 cm vials 
containing standard medium (8.3%, w/v maize flour; 5%, w/v 
glucose; 2.5%, w/v sucrose; 1.5%, w/v agar; 2%, w/v yeast 
powder; 0.04%, v/w propionic acid; 0.6%, v/w 
orthophosphoric acid; 0.7%, v/w methyl paraben) at constant 
temperature and humidity (23°C±1°C; 60% relative humidity, 
respectively) under 12 h dark-light cycle. All experiments 
were performed with the same strain. 
The powders were macerated for 8 hours using the solvent 
petroleum ether for defatting of the material. Crude extracts 
were obtained by placing 20-30 gm of powder in the soxhlet 
extractor using ethanol at 40°C. The crude extract that is 
EEBC and EEGS were further evaporated in the Rotavac 
evaporator and were dried to get the free flowing powder. The 
powders were stored in airtight container. 
ROT treatedflies were exposed to low and high doses of 
EEBC & EEGS mixed in the culture medium. EEBC (0.05% 
w/v and 0.1% w/v) & EEGS (0.05% w/v and 0.1% w/v) were 
added in the medium at final concentrations of 5 mg/ml, 10 
mg/ml. Vials of flies without test compound and ROT were 
used as control. Flies (male adult, 7–8 days old) were divided 
into six groups: (1) Control; (2) ROT (500 μM); (3) ROT plus 
EEBC (0.05% w/v); (4) ROT plus EEBC (0.1% w/v); (5) ROT 
plus EEGS (0.05% w/v) and (6) ROT plus EEGS (0.1% w/v). 
The total food medium contained a volume of 1% of ROT or 
ROT plus EEBC or EEGS. The flies were exposed to 
treatments during 7 days and the vials containing flies were 
maintained. 
The motor function was assessed using a negative geotaxis 
assay. During their light cycle, 15 flies were transferred into a 
graduated flat bottom glass tube (length 12 cm; diameter 2 
cm) and allowed to habituate for at least 5 min. The tube were 
gently tapped at the bottom and observed for 60 sec. for the 
climbing activity (15 flies/trial; 3 trials were done). Locomotor 
behaviour was expressed as percent flies escaping beyond a 
minimum distance of 10 cm in 60 sec
[20]
. 
All the data were expressed as mean ± standard error of the 
mean (SEM). Statistical significance was tested using oneway 
ANOVA followed by Tukey’s multiple comparisons test using 
Prism Graph Pad version 7.0 (Graph Pad software, Inc., CA). 
*p < 0.05 was considered statistically significant. 
The results of this study revealed that response of the PD 
induced flies were significantly lower than that of control 
flies. Measurement of the locomotor deficits among flies of 
ROT treated exhibited severe locomotor impairments as 
evident by the large number of flies (97.73%) staying at the 
bottom of the glass vial. The flies co-treated with EEBC 
(0.05% w/v & 0.1% w/v)& EEGS (0.05% w/v & 0.1% w/v) 
significantly (p< 0.05) improved the locomotor activity when 
compared with ROT treated flies (Table 1 & Figure 1). The 
average number of flies staying at the bottom of vial was 
decreased to 66.63% when co-treated with EEBC & EEGS.  
The flies showed negative geotaxis behaviour treated with 
EEBC & EEGS dose dependently; indicating its 
neuroprotective effect. 
 
Table1. Effect of EEBC & EEGS on locomotor activity in Drosophila melanogaster 
Groups No. of flies escaped beyond 10 cm distance % protection 
Vehicle Control 11.67±0.88 77.80 
Disease Control 0.33±0.33 2.27 
EEBC(0.05% w/v) 3.67±0.67* 24.47 
EEBC(0.1% w/v) 6.34±0.33* 42.27 
EEGS(0.05% w/v) 3.67±0.67* 24.47 
EEGS(0.1% w/v) 6.34±0.33* 42.27 
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Values are expressed as mean ± SEM; n=15, where n is the 
number of flies per group. *indicates there is significant 
difference with  p< 0.05 when compared with disease control 
group by One-way ANOVA followed by Tukey’s multiple 
comparisons test.  
 
Fig. 1: Effect of EEBC & EEGS on locomotor activity in Drosophila 
melanogaster by negative geotaxis assay 
 
In Drosophila model, ROT is commonly used for PD model. It 
has high affinity specific inhibitor of mitochondrial (complex 
I) NADH dehydrogenase. Being highly lipophilic, it crosses 
the blood brain barrier rapidly and accumulates in subcellular 
organelles like mitochondria 
[21]
; where oxidative damage 
leads to neurotoxicity of dopaminergic neurons and locomotor 
deficits 
[22,23]. In ROT (500 μM) induced significant locomotor 
impairment in flies as indicated by large number of flies 
remaining at bottom of vials in disease control group. The 
EEBC & EEGS at doses of 0.05% w/v and 0.1% w/v showed 
protective effect against ROT induced locomotor impairment 
exhibited significant improvement in locomotor activity, thus 
could be proved with possible action on central nervous 
system indicates that EETP has an ability of free radical 
scavenging properties helps in neuroprotection of 
dopaminergic neurons in brain. 
In summary, this study demonstrated that EEBC & EEGS 
improves locomotor performance and reduce the toxicity in 
ROTinducedD. melanogaster fly PD model. This study 
confirms the utility of this model to investigate therapeutic 
strategies that may be promising in the treatment of 
neurodegenerative diseases and can be used for studies in 
higher rodent model. 
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